Clicky

LeMaitre Vascular, Inc.(LMAT)

Description: LeMaitre Vascular, Inc., together with its subsidiaries, engages in the development, manufacture, and marketing of medical devices and implants for the treatment of peripheral vascular disease worldwide. Its products include embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters; perfusion catheters that temporarily perfuse blood and other liquids into the vasculature; carotid shunts to temporarily divert blood to the brain during the removal of plaque from the carotid artery; and laparoscopic cholecystectomy devices to inject dye into the cystic duct during laparoscopic cholecystectomy. The company also offers manual contrast injectors for the injection of contrast media into blood vessels; modeling catheters to apply radial pressure to the inside of an aortic stent graft for sealing; radiopaque tape to improve the precision of vascular and endovascular procedures; and remote endarterectomy devices to remove severe atherosclerotic blockages from the arteries of the leg. In addition, it provides valvulotomes for use as a bypass vessel to carry blood past diseased arteries to the lower leg or the foot; vascular grafts to bypass or replace diseased arteries; vascular patches that are synthetic and biological patches for use in closing incisions in a blood vessel; vein strippers for single-incision removal of varicose veins; and vessel closure systems to attach blood vessels for dialysis access. LeMaitre Vascular, Inc. markets its products through direct and indirect sales force, and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.


Keywords: Medicine Catheter Dialysis Interventional Radiology Vascular Disease Neurosurgery Bypass Artery Vascular Surgery Cardiovascular System Injector Incision Perfusion Veins Closure Systems Blood Clots Incisions Peripheral Artery Disease Peripheral Vascular Disease Contrast Media Embolectomy Shunt Varicose Veins Vascular Bypass

Home Page: www.lemaitre.com

LMAT Technical Analysis

63 Second Avenue
Burlington, MA 01803
United States
Phone: 781 221 2266


Officers

Name Title
Mr. George W. LeMaitre Chairman & CEO
Mr. David B. Roberts Pres & Director
Mr. Joseph P. Pellegrino Jr. CFO, Treasurer, Sec. & Director
Mr. Trent G. Kamke Sr. VP of Operations
Dr. George D. LeMaitre Founder and Chairman of Scientific Advisory Board
Ms. Laurie A. Churchill Sr. VP & Gen. Counsel
Ms. Kimberly L. Cieslak VP of Marketing
Mr. Daniel J. Mumford Director of HR
Mr. Andrew Hodgkinson Sr. VP of Clinical, Regulatory & Quality Affairs
Mr. Stephane Maier Sr. VP of EMEA Operations

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 40.3226
Trailing PE: 48.4255
Price-to-Book MRQ: 4.0406
Price-to-Sales TTM: 6.2693
IPO Date: 2006-10-19
Fiscal Year End: December
Full Time Employees: 450
Back to stocks